16
Jun
2026
CHUNGHWA CHEMICAL SYNTHESIS & Biotech Co. Ltd.,
Exhibitor at CPHI & PMEC China 2026 stand E1D22a, Pharma Ingredients
About Us
Categories
-
Country/Region:Taiwan
-
On CPHI since:2015
-
Employees:250 - 499
Company types
Event information
CPHI & PMEC China 2026
-
16 Jun 2026 - 18 Jun 2026
-
Shanghai New International Expo Center
-
Visit us at stand E1D22a, Pharma Ingredients
Products Featured at CPHI & PMEC China 2026
-
Product Eevrolimus
Anticancer/Immunosuppressant -
Product Everolimus
Chunghwa chem synthesis & biotech co. offers a wide range of api products which includes everolimus. It belongs to immunosuppressant and oncology category. Contact us for more information. -
Product Semaglutide
CCSB commercialized fermentation and semi-synthesis products like Tacrolimus, Everolimus, Sirolimus and Caspofungin Acetate and are in position to offer the these expertises to Semaglutide API. -
Product Tacrolimus
Chunghwa chem synthesis & biotech co. offers a wide range of api products which includes tacrolimus. It belongs to immunosuppressant category. Contact us for more information. -
Product Caspofungin Acetate
Chunghwa chem synthesis & biotech co. offers a wide range of api products which includes caspofungin acetate. It belongs to antifungal category. Contact us for more information.
